Medical Devices News and Research

RSS

XTRAC Excimer Laser treatment offers new hope for patients with psoriasis

With XTRAC® Excimer Laser treatments, psoriasis patients can say goodbye to the red, dry patches of scaly, thickened skin they have been covering up all winter. Developed by PhotoMedex, Inc., an innovator of medical devices, the XTRAC laser offers new hope to the 7.5 million Americans suffering from this embarrassing and socially isolating disease.

19 May 2011

Momentive Performance Materials collaborates with SSF to develop combination products

Momentive Performance Materials Inc. today announced a collaboration initiative with Specialty Silicone Fabricators (SSF) to develop combination products for medical devices manufacturers.

18 May 2011

Clinipace Worldwide announces acquisition of PFC

Clinipace Worldwide, a global digital clinical research organization, and Swiss-based PFC Pharma Focus today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of privately-held PFC and its subsidiaries.

18 May 2011

Nano Bridging Molecules SA receives CE marking certification for SurfLink dental product

Nano Bridging Molecules SA, A Swiss med-tech company announced that it has received CE Mark (Conformité Européenne) approval to begin marketing its SurfLink® Dental product. With its bio mimicking properties, SurfLink® Dental has been shown to allow for natural and permanent integration of dental implants for the first time. Bone seems to perceive the SurfLink® Dental product as ‘body-like’ and integrates the implant with a natural healing process, resulting in a quicker healing and a more stable integration, than without this product.

18 May 2011

CryoLife acquires Cardiogenesis

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has successfully completed its acquisition of Cardiogenesis Corporation.

17 May 2011

FDA grants 510(k) clearance to Asante's Pearl Insulin Pump

Asante Solutions, Inc., a medical device company focused on diabetes care, announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the company's Pearl Insulin Pump. Last month, the Pearl also received the CE Mark, a European proof of conformity that certifies the product meets EU safety, health and environmental requirements.

17 May 2011

Bioengineering students redesign pediatric mannequin

Rice University bioengineering students have modified a child-size training mannequin to give medical students hands-on pediatric experience so that real patients can be spared further stress and pain.

17 May 2011

ESC calls for single co-ordinated European system to oversee evaluation, approval of medical devices

The European Society of Cardiology (ESC) is calling for a single, co-ordinated European system to oversee the evaluation and approval of medical devices. The call is being made in a paper published online in the European Heart Journal reporting on a conference held by the ESC in January 2011 looking to increase the input of medical experts in developing medical device policy.

17 May 2011

InVivo Therapeutics reports net loss of $1,278,000 for first quarter 2011

InVivo Therapeutics, a medical device company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, today reported financial results for the first quarter 2011.

16 May 2011

China Kanghui first quarter total net revenue increases 39.3% to RMB68.0 million

China Kanghui Holdings, a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced financial results for the first quarter of 2011.

16 May 2011

New circumcision treatment can reduce HIV

Promising study results published in the May issue of JAIDS show that a novel medical device has the potential to revolutionize how male circumcision services are offered in countries hardest hit by the HIV epidemic.

13 May 2011

PLC Systems to showcase RenalGuard at 2011 EAPCI annual meeting

PLC Systems Inc., a company focused on innovative medical device technologies, today announced it will demonstrate its innovative new product, RenalGuard, at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions.

12 May 2011

InTouch Health applauds FDA for recent announcement on Medical Device Data Systems

In response to the recent announcement issued by the Food and Drug Administration regarding Medical Device Data Systems, InTouch Health affirms its position of compliance, and applauds the agency for issuing regulations governing the use of hardware and software in the healthcare information technology space.

12 May 2011

Medtronic to present new clinical results on innovative medical devices at EuroPCR

New clinical data on a range of innovative medical devices from Medtronic, Inc., to treat cardiac and vascular diseases - from severe aortic stenosis and uncontrolled hypertension, to coronary and peripheral artery disease - will be presented next week at EuroPCR. Many of the presentations will be featured during late-breaking sessions at this large international interventional cardiology meeting, which takes place in Paris from May 17-20.

From Medtronic 12 May 2011

Prostrate cancer patients can benefit from new MRI-ultrasound fusion

Targeted biopsy, a major advance in prostate cancer diagnostics, was detailed by a UCLA team in the current issue of Urologic Oncology. The new technology fuses MRI with real-time 3D ultrasound, providing an exacting method to obtain biopsy specimens from suspicious areas in the prostate.

12 May 2011

TSO3 first quarter revenue decreases to $136,628

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings, posted revenues of $136,628 for the first quarter of 2011 ending March 31, for the sale of supplies, accessories and service contracts for the first generation product.

11 May 2011

ICON partners with BCRI for clinical research

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced a strategic alliance with Boston Clinical Research Institute, an Academic Research Organisation based in Boston, Massachusetts.

11 May 2011

Aethlon seeks FDA meeting for re-initiation of Hemopurifier IDE study

Aethlon Medical, Inc. announces that it has submitted a request to the U.S. Food and Drug Administration for a face-to-face meeting to discuss re-initiation of an Investigational Device Exemption (IDE) study of the Aethlon Hemopurifier in the United States.

10 May 2011

Osiris Therapeutics net income increases to $4.0 million for first quarter 2011

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, cardiovascular, wound care and orthopedic areas, announced today its results for the first quarter ended March 31, 2011.

10 May 2011

STERIS fourth quarter revenue increases 14% to $377.8 million

STERIS Corporation today announced financial results for its fiscal 2011 fourth quarter ended March 31, 2011. Fiscal 2011 fourth quarter revenue increased 14% to $377.8 million compared with $332.1 million in the fourth quarter of fiscal 2010, with growth in all three business segments.

9 May 2011